Related Experiment Video
Updated: Dec 28, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
[Effect of sublingual immunotherapy on patients with allergic rhinitis]
1Department of Otolaryngology Head and Neck Surgery,Yongchuan Hospital Affiliated to Chongqing Medical University,Chongqing,402160,China.
Abstract:
Objective:Study the efficacy of sublingual immunotherapy (SLIT) for monosensitized and polysensitized allergic rhinitis patients of different severity. Method:According to the results of intradermal experiments, 186 patients with AR who were treated with standardized dust mites SLIT for 2 years. These patients have been divided into mild monosensitized group and mild polysensitized group, moderate monosensitized group and moderate polysensitized group, severe monosensitized group and severe polysensitized group. Statistics and analysis of total nasal symptom score (TNSS), total medication score (TMS) , visual analog scale (VAS) about before and after SLIT treatment. Result:Before SLIT treatment and after 2 years, the TNSS: Mild monosensitized group (5. 58±1. 68)(0. 58±0. 75), mild polysensitized group(5. 34±1. 49)(0. 93±0. 75);moderate monosensitized group (4. 68±1. 55)(0. 32±0. 63), moderate polysensitized group(6. 26±1. 46)(0. 61±0. 67),which have showed a statistically significant difference(P<0.05),between the two groups have no significant difference (P>0.05). Severe monosensitized group(6. 26±0. 73)(1. 16±1. 13), severe polysensitized group(6. 49±1. 04)(1. 89±1. 07), which have showed a statistically significant difference(P<0.05), between the two groups have a statistically significant difference(P<0.05). The VAS:Mild monosensitized group (6. 09±1. 23)(1. 52±1. 25), mild polysensitized group(6. 21±0. 90)(1. 97±1. 18),moderate monosensitized group(6. 12±0. 53)(1. 16±1. 03), moderate polysensitized group(6. 65±1. 08)(1. 65±0. 98),which have showed a statistically significant difference(P<0.05),between the two groups have no significant difference (P>0.05). Severe monosensitized group(6. 26±0. 73)(1. 16±1. 13), severe polysensitized group(6. 49±1. 04)(1. 89±1. 07), which have showed a statistically significant difference(P<0.05), between the two groups have a statistically significant difference(P<0.05). The TMS:These have showed a statistically significant difference(P<0.05)with same group,between all groups have no significant difference (P>0.05). Conclusion:Dust mites under the SLIT are effective for monosensitized and polysensitized allergic patients. For patients with severe polysensitized , it is necessary to extend the treatment time (>2 years).
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Allergic Drug Reactions
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

